Colloidal aggregation affects the efficacy of anticancer drugs in cell culture

ACS Chemical Biology

Volumn 7, Issue 8, 2012, Pages 1429-1435

  Owen, Shawn C ^a   Doak, Allison K ^b   Wassam, Pascal ^b   Shoichet, Molly S ^a   Shoichet, Brian K ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEXAROTENE; CRIZOTINIB; FULVESTRANT; LAPATINIB; NILOTINIB; SORAFENIB; VEMURAFENIB;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; COLLOID; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; ENZYME INHIBITION; HYDROPHOBICITY; IC 50; MOLECULAR STABILITY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ADSORPTION; ALBUMINS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLLOIDS; CULTURE MEDIA; DRUG SCREENING ASSAYS, ANTITUMOR; EVANS BLUE; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; LIGHT; MACROMOLECULAR SUBSTANCES; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, CHEMICAL; SCATTERING, RADIATION;

EID: 84865256887     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300189b     Document Type: Article

References (28)

1. Roche, O., Schneider, P., Zuegge, J., Guba, W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E. M., Rogers-Evans, M., Neidhart, W., Stalder, H., Dillon, M., Sjogren, E., Fotouhi, N., Gillespie, P., Goodnow, R., Harris, W., Jones, P., Taniguchi, M., Tsujii, S., von der Saal, W., Zimmermann, G., and Schneider, G. (2002) Development of a virtual screening method for identification of "frequent hitters" in compound libraries J. Med. Chem. 45, 137-142
2. Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., and Austin, C. P. (2007) A high-throughput screen for aggregation-based inhibition in a large compound library J. Med. Chem. 50, 2385-2390
3. McGovern, S. L., Helfand, B. T., Feng, B., and Shoichet, B. K. (2003) A specific mechanism of nonspecific inhibition J. Med. Chem. 46, 4265-4272
4. McGovern, S. L., Caselli, E., Grigorieff, N., and Shoichet, B. K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 45, 1712-1722
5. Coan, K. E., Maltby, D. A., Burlingame, A. L., and Shoichet, B. K. (2009) Promiscuous aggregate-based inhibitors promote enzyme unfolding J. Med. Chem. 52, 2067-2075
6. Ryan, A. J., Gray, N. M., Lowe, P. N., and Chung, C. W. (2003) Effect of detergent on "promiscuous" inhibitors J. Med. Chem. 46, 3448-3451
7. Feng, B. Y. and Shoichet, B. K. (2006) A detergent-based assay for the detection of promiscuous inhibitors Nat. Prot. 1, 550-553
8. Thorne, N., Auld, D. S., and Inglese, J. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr. Opin. Chem. Biol. 2010, 14, 315-324.
9. Seidler, J., McGovern, S. L., Doman, T. N., and Shoichet, B. K. (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs J. Med. Chem. 46, 4477-4486
10. McGovern, S. L. and Shoichet, B. K. (2003) Kinase inhibitors: not just for kinases anymore J. Med. Chem. 46, 1478-1483
11. Doak, A. K., Wille, H., Prusiner, S. B., and Shoichet, B. K. (2010) Colloid formation by drugs in simulated intestinal fluid J. Med. Chem. 53, 4259-4265
12. Frenkel, Y. V., Clark, A. D., Jr., Das, K., Wang, Y. H., Lewi, P. J., Janssen, P. A., and Arnold, E. (2005) Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability J. Med. Chem. 48, 1974-1983
13. Coan, K. E. and Shoichet, B. K. (2007) Stability and equilibria of promiscuous aggregates in high protein milieus Molecular bioSystems 3, 208-213
14. Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C., Prusiner, S. B., Weissman, J., and Shoichet, B. K. (2008) Small-molecule aggregates inhibit amyloid polymerization Nat. Chem. Biol. 4, 197-199
15. Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., and Shoichet, B. K. (2005) High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 1, 146-148
16. Fang, J., Nakamura, H., and Maeda, H. (2010) The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Delivery Rev. 63, 136-151
17. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46, 3-26
18. Jadhav, A., Ferreira, R. S., Klumpp, C., Mott, B. T., Austin, C. P., Inglese, J., Thomas, C. J., Maloney, D. J., Shoichet, B. K., and Simeonov, A. (2009) Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease J. Med. Chem. 53, 37-51
19. Melnick, J. S., Janes, J., Kim, S., Chang, J. Y., Sipes, D. G., Gunderson, D., Jarnes, L., Matzen, J. T., Garcia, M. E., Hood, T. L., Beigi, R., Xia, G., Harig, R. A., Asatryan, H., Yan, S. F., Zhou, Y., Gu, X. J., Saadat, A., Zhou, V., King, F. J., Shaw, C. M., Su, A. I., Downs, R., Gray, N. S., Schultz, P. G., Warmuth, M., and Caldwell, J. S. (2006) An efficient rapid system for profiling the cellular activities of molecular libraries Proc. Natl. Acad. Sci. U.S.A. 103, 3153-3158
20. Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D., and Duhr, S. (2010) Protein-binding assays in biological liquids using microscale thermophoresis Nat. Commun. 1, 100
21. Shoichet, B. K. (2006) Interpreting steep dose-response curves in early inhibitor discovery J. Med. Chem. 49, 7274-7277
22. Coan, K. E. and Shoichet, B. K. (2008) Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors J. Am. Chem. Soc. 130, 9606-9612
23. Moore, F. D. and Tobin, L. H. (1942) Studies with Radioactive Di-Azo Dyes. 1. the Localization of Radioactive Di-Brom Trypan Blue in Inflammatory Lesions J. Clin. Invest. 21, 471-481
24. Rawson, R. A. (1942) The binding of T-1824 and structurally related diazo dyes by the plasma proteins Am. J. Physiol. 138, 10
25. von Porat, B. (1951) Blood volume determinations with the Evans blue dye method Acta Med. Scand. 139, 13-18
26. Matsumura, Y. and Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46, 6387-6392
27. Leveen, H. H. and Fishman, W. H. (1947) Combination of Evans blue with plasma protein: its significance in capillary permeability studies, blood dye disappearance curves, and its use as a protein tag Am. J. Physiol. 151, 8
28. du Manoir, J. M., Francia, G., Man, S., Mossoba, M., Medin, J. A., Viloria-Petit, A., Hicklin, D. J., Emmenegger, U., and Kerbel, R. S. (2006) Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts Clin. Cancer Res. 12, 904-916